GlassScriptPhysician profile
Scott Wentz
NPI 1114312089
$3,658.45
in general payments reported to CMS, 2019-2025
19 companies · $594 in 2025
The $594 reported for 2025 was more than what 82% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $680 · 2020: $153 · 2021: $286 · 2022: $631 · 2023: $240 · 2024: $1,074 · 2025: $594.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,908.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,908.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,156.14 | 2019-2025 | Clareon, Clareon Panoptix Pro, Rocklatan |
| Sun Pharmaceutical Industries INC. | $349.84 | 2021-2025 | Cequa |
| Rxsight INC | $314.52 | 2024 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Injector Handpiece |
| Kala Pharmaceuticals, INC. | $254.05 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $200.52 | 2019 | |
| Abbvie INC. | $191.10 | 2022-2025 | Lumigan, Vuity |
| Tarsus Pharmaceuticals, INC. | $187.80 | 2024-2025 | Xdemvy |
| Aerie Pharmaceuticals, INC. | $151.11 | 2020-2021 | |
| Sight Sciences, INC. | $148.26 | 2024 | Omni Surgical System |
| Bausch & Lomb Americas INC. | $114.21 | 2024-2025 | Miebo, Xiidra, Vyzulta |
| Thea Pharma INC. | $102.42 | 2022-2024 | Iyuzeh |
| Spark Therapeutics, INC. | $100.30 | 2019 | |
| Harrow Eye, LLC | $96.98 | 2024-2025 | Vevye, Iheezo, Triesence |
| Biotissue Holdings INC. | $86.33 | 2021-2025 | |
| Allergan, INC. | $79.89 | 2020-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $48.89 | 2024-2025 | Baerveldt Glaucoma Implant (250), Tecnis Simplicity |
| Oyster Point Pharma, INC. | $34.39 | 2022 | |
| Alimera Sciences, INC. | $21.28 | 2024 | Iluvien, Yutiq |
| Amgen INC. | $20.42 | 2024 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Wentz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.